What is the ROCE (Return on Capital Employed) of Chimerix this year?
The ROCE of Chimerix is -0.48 undefined this year.
Chimerix ROCE 2024
Chimerix ROCE
-0.48
Ticker
CMRX
ISIN
US16934W1062
WKN
A1T65B
In 2024, Chimerix's return on capital employed (ROCE) was -0.48, a 105.02% increase from the -0.24 ROCE in the previous year.
Chimerix Aktienanalyse
What does Chimerix do?
Chimerix Inc is a biopharmaceutical company focused on the development of antiviral drugs. The company was founded in 2002 and is headquartered in Durham, North Carolina. The history of Chimerix dates back to the research of Dr. George Painter, a renowned scientist in the field of antiviral therapy. He discovered that a certain group of molecules, known as nucleoside analogues, have antiviral properties. The idea was to use these molecules as a starting point for the development of drugs that specifically target viruses. The core idea of Chimerix was to create a new business model that is different from traditional pharmaceutical companies. Instead of focusing on the lengthy and costly development of new compounds, the company wanted to utilize existing molecules and create new drugs through targeted modifications. This approach was not only expected to be faster and cost-effective but also to offer higher chances of success. Chimerix is divided into several business segments. The most important segment is antiviral therapy, where the company focuses on developing drugs against various viruses such as Cytomegalovirus (CMV), Adenovirus, and Herpesvirus. Another business segment of Chimerix is oncology. Here, the company also relies on modifying existing compounds to develop new and effective cancer drugs. One promising molecule currently being developed is Brincidofovir, which not only has antiviral properties but also possesses antitumor properties. In addition to drug development, Chimerix also offers support for clinical trials. The company collaborates with various research institutions and biopharmaceutical companies to test the efficacy and safety of new compounds. The most well-known product of Chimerix is Brincidofovir. This antiviral drug is currently being tested in clinical trials and has the potential to be used against a range of viruses. Its use is particularly promising in patients undergoing immunosuppressive therapy, such as those after a stem cell transplant. Chimerix aims to develop innovative and effective drugs that help patients overcome serious diseases. With its unique business model and close collaboration with the research community, the company has already made promising progress and is an important player in the field of antiviral therapy and oncology. Chimerix ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Chimerix's Return on Capital Employed (ROCE)
Chimerix's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Chimerix's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Chimerix's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Chimerix’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Chimerix Stock
How has the ROCE (Return on Capital Employed) of Chimerix developed compared to the previous year?
The ROCE of Chimerix has increased by 105.02% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Chimerix?
A high Return on Capital Employed (ROCE) indicates that Chimerix has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Chimerix?
A low ROCE (Return on Capital Employed) can indicate that Chimerix has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Chimerix impact the company?
An increase in the ROCE of Chimerix can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Chimerix affect the company?
A decrease in ROCE of Chimerix can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Chimerix?
Some factors that can affect Chimerix's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Chimerix so important for investors?
The ROCE of Chimerix is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Chimerix take to improve the ROCE?
To improve the ROCE, Chimerix can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Chimerix pay?
Over the past 12 months, Chimerix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chimerix is expected to pay a dividend of 0 USD.
What is the dividend yield of Chimerix?
The current dividend yield of Chimerix is .
When does Chimerix pay dividends?
Chimerix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Chimerix?
Chimerix paid dividends every year for the past 0 years.
What is the dividend of Chimerix?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Chimerix located?
Chimerix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Chimerix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Chimerix from 6/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.
When did Chimerix pay the last dividend?
The last dividend was paid out on 6/26/2024.
What was the dividend of Chimerix in the year 2023?
In the year 2023, Chimerix distributed 0 USD as dividends.
In which currency does Chimerix pay out the dividend?
The dividends of Chimerix are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Chimerix
Our stock analysis for Chimerix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chimerix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
